These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15914522)

  • 21. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
    Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
    Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical performance of three bolus calculators in subjects with type 1 diabetes mellitus: a head-to-head-to-head comparison.
    Zisser H; Wagner R; Pleus S; Haug C; Jendrike N; Parkin C; Schweitzer M; Freckmann G
    Diabetes Technol Ther; 2010 Dec; 12(12):955-61. PubMed ID: 21128842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.
    Blasetti A; Di Giulio C; Tocco AM; Verrotti A; Tumini S; Chiarelli F; Altobelli E
    Pediatr Diabetes; 2011 Feb; 12(1):4-10. PubMed ID: 20723102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients.
    Yardley JE; Iscoe KE; Sigal RJ; Kenny GP; Perkins BA; Riddell MC
    Diabetes Technol Ther; 2013 Jan; 15(1):84-8. PubMed ID: 23216304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.
    Pańkowska E; Szypowska A; Lipka M; Szpotańska M; Błazik M; Groele L
    Pediatr Diabetes; 2009 Aug; 10(5):298-303. PubMed ID: 19175902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.
    Skogsberg L; Fors H; Hanas R; Chaplin JE; Lindman E; Skogsberg J
    Pediatr Diabetes; 2008 Oct; 9(5):472-9. PubMed ID: 18721168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of emerging new technologies.
    Garg SK
    Diabetes Technol Ther; 2008 Oct; 10(5):413-4. PubMed ID: 18715219
    [No Abstract]   [Full Text] [Related]  

  • 29. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin treatment reduces pre-prandial plasma ghrelin concentrations in children with type 1 diabetes.
    Ashraf A; Mick G; Meleth S; Wang X; McCormick K
    Med Sci Monit; 2007 Dec; 13(12):CR533-7. PubMed ID: 18049431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Metabolic Parameters and Treatment Method on OCT Angiography Results in Children with Type 1 Diabetes.
    Wysocka-Mincewicz M; Baszyńska-Wilk M; Gołębiewska J; Olechowski A; Byczyńska A; Hautz W; Szalecki M
    J Diabetes Res; 2020; 2020():4742952. PubMed ID: 33294460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania.
    Mukama LJ; Moran A; Nyindo M; Philemon R; Msuya L
    Pediatr Diabetes; 2013 May; 14(3):211-6. PubMed ID: 23350587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique Challenges of Type 1 Diabetes in the Preschool Population.
    Coshway LK; Hoffman RP
    Curr Diabetes Rev; 2017; 13(2):122-131. PubMed ID: 26490431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
    Barter PJ; Rye KA; Tardif JC; Waters DD; Boekholdt SM; Breazna A; Kastelein JJ
    Circulation; 2011 Aug; 124(5):555-62. PubMed ID: 21804130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The assessment of the correlation between vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF-alpha), interleukin 6 (IL-6), glycaemic control (HbA1c) and the development of the diabetic retinopathy in children with diabetes mellitus type 1].
    Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
    Klin Oczna; 2007; 109(4-6):150-4. PubMed ID: 17725274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Willi SM; Planton J; Egede L; Schwarz S
    J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.
    Lundberg RL; Marino KR; Jasrotia A; Maranda LS; Barton BA; Alonso LC; Nwosu BU
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):823-830. PubMed ID: 28753540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis.
    Redondo MJ; Connor CG; Ruedy KJ; Beck RW; Kollman C; Wood JR; Buckingham B; Klingensmith GJ; Silverstein J; Tamborlane WV;
    Pediatr Diabetes; 2014 Jun; 15(4):294-302. PubMed ID: 23889707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis.
    Dovc K; Telic SS; Lusa L; Bratanic N; Zerjav-Tansek M; Kotnik P; Stefanija MA; Battelino T; Bratina N
    Diabetes Technol Ther; 2014 Jan; 16(1):33-40. PubMed ID: 24131373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.